Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · May 2017
Randomized Controlled TrialPharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial.
To assess the effect of a community pharmacist-led intervention on the proportion of patients with diabetes placed on statin therapy. ⋯ Through a brief pharmacist-to-provider intervention, a significant gap closure in statin therapy was seen in patients with diabetes. There is an opportunity for pharmacies, health plans, and prescribers to utilize the community pharmacist in achieving quality, evidence-based patient care.
-
J Am Pharm Assoc (2003) · May 2017
Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
To describe the integration and implementation of pharmacy services in patient-centered medical homes (PCMHs) as adopted by federally qualified health centers (FQHCs) and compare them with usual care (UC). ⋯ PCMH pharmacists in FQHCs were integrated into the workflow to address specific patient needs. Specifically, full-time in-house pharmacists, flexible referral criteria, proactive screening, well defined collaborative practice agreement, and open scheduling were successful strategies for the underserved populations in this study. However, reimbursement plans and provider status for pharmacists should be established to sustain this model of care.
-
J Am Pharm Assoc (2003) · May 2017
Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
To assess community pharmacists' attitudes toward working with patients who have severe and persistent mental illness (SPMI) and to identify perceived barriers to providing care and services to this population. ⋯ Although pharmacists had a positive attitude toward working with this population, multiple barriers were identified that prevented optimal care. Identifying solutions to overcome these barriers could help to improve the overall care and increase the likelihood of success in treating patients with SPMI.
-
J Am Pharm Assoc (2003) · May 2017
Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D.
Pain is the most prevalent problem among veterans, who receive pain diagnoses 5 times more frequently than the general population. Opioids are commonly prescribed for pain, but they have potential for misuse and serious adverse events. The study objective was to evaluate opioid dispensing patterns and predictors for overlap in veterans who are eligible for Medicare Part D benefits. ⋯ Opioids dispensed from Part D-reimbursed pharmacies had a higher frequency of overlapping days' supply as compared to those filled by the VA, but there was minimal overlap between systems. While overlapping opioid prescriptions filled by the VA decreased from 2007 to 2009, overlap increased for prescriptions filled at Part D-reimbursed pharmacies. Tools, such as drug monitoring programs, should be used by VA and non-VA providers to decrease opioid-related harms and misuse.
-
J Am Pharm Assoc (2003) · May 2017
Community pharmacy transition of care services and rural hospital readmissions: A case study.
To explore community pharmacist involvement in the transition of care (TOC) process for patients discharged with acute myocardial infarction (AMI), heart failure (HF), pneumonia, chronic obstructive pulmonary disease (COPD), or elective total hip or knee arthroplasty (THA/TKA). ⋯ Community pharmacist involvement in the TOC process may help to prevent readmissions for patients with AMI, HF, pneumonia, COPD, and elective THA/TKA. Patients are overall satisfied with community pharmacist involvement as they move from inpatient care to home. In addition, there are multiple barriers affecting access and adherence to medication therapy while at home, providing opportunities for pharmacist intervention and assistance.